|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
19
|
|
pubmed:dateCreated |
2003-5-8
|
|
pubmed:abstractText |
High-dose therapy with supporting autologous stem-cell transplantation remains a controversial treatment for cancer. In multiple myeloma, first-line regimens incorporating high-dose therapy yield higher remission rates than do conventional-dose treatments, but evidence that this translates into improved survival is limited.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
1533-4406
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright 2003 Massachusetts Medical Society
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
8
|
|
pubmed:volume |
348
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1875-83
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:12736280-Adult,
pubmed-meshheading:12736280-Aged,
pubmed-meshheading:12736280-Antineoplastic Agents, Alkylating,
pubmed-meshheading:12736280-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:12736280-Carmustine,
pubmed-meshheading:12736280-Cause of Death,
pubmed-meshheading:12736280-Combined Modality Therapy,
pubmed-meshheading:12736280-Cyclophosphamide,
pubmed-meshheading:12736280-Doxorubicin,
pubmed-meshheading:12736280-Female,
pubmed-meshheading:12736280-Hematopoietic Stem Cell Transplantation,
pubmed-meshheading:12736280-Humans,
pubmed-meshheading:12736280-Male,
pubmed-meshheading:12736280-Melphalan,
pubmed-meshheading:12736280-Middle Aged,
pubmed-meshheading:12736280-Multiple Myeloma,
pubmed-meshheading:12736280-Prognosis,
pubmed-meshheading:12736280-Survival Analysis
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma.
|
|
pubmed:affiliation |
Academic Unit of Haematology and Oncology, Cancer Research United Kingdom Clinical Centre, University of Leeds, Leeds, United Kingdom. tony.child@leedsth.nhs.uk
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study,
Clinical Trial, Phase III
|
